홈 › 위암 › 미시간 › Grand Rapids
MI Grand Rapids의 위암 임상 시험
위암 관련 연구 18개가 Grand Rapids 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
피험자 모집 중건강한 지원자 환영
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
피험자 모집 중2상
- Research Site, Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
피험자 모집 중1상
- BAMF Health Inc., Grand Rapids
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
피험자 모집 중1상
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- START Midwest, Grand Rapids
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
피험자 모집 중1/2상
- START Midwest, Grand Rapids
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
피험자 모집 중3상
- Research Site, Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- START - Midwest Cancer Research Center, Grand Rapids
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
피험자 모집 중1/2상
- START Midwest, LLC, Grand Rapids
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Research Site, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- START Midwest, Grand Rapids
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
피험자 모집 중1상
- START Midwest, Grand Rapids
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
피험자 모집 중1상
- START Midwest /ID# 248685, Grand Rapids
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
피험자 모집 중2/3상
- BAMF Health, Grand Rapids
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
피험자 모집 중2상
- Research Site, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
피험자 모집 중1/2상
- START Midwest, Grand Rapids
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
피험자 모집 중1/2상
- BAMF Health, Inc., Grand Rapids
다른 도시의 위암 시험
- Houston, TX연구 42개
- Boston, MA연구 32개
- New York City, NY연구 31개
- Nashville, TN연구 28개
- Baldwin Park, CA연구 22개
- Los Angeles, CA연구 22개
- Arlington, VA연구 20개
- Dallas, TX연구 19개
- San Antonio, TX연구 19개
- St. Louis, MO연구 18개
- Washington, DC연구 16개
- Chicago, IL연구 16개
Grand Rapids의 다른 연구
- 비소세포폐암연구 44개
- 대장직장암연구 40개
- 암 (전체)연구 28개
- 유방암연구 26개
- 난소암연구 24개
- 전이성 암연구 22개
- 전립선암연구 19개
- 자궁내막암연구 18개
- 췌장암연구 18개
- 흑색종연구 17개
- 두경부 편평세포암연구 15개
- 삼중음성 유방암연구 15개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.